期刊文献+

氯苯丁酯对雌性肥胖Zucker大鼠心肌甘油三酯积聚的影响

Effect of Clofibrate on Myocardial Triglyceride Accumulation in Female Obese Zucker Rats
下载PDF
导出
摘要 目的观察氯苯丁酯对雌性肥胖Zucker大鼠心肌甘油三酯积聚的影响,以探讨其在脂毒性心肌病中的应用。方法选择瘦型和肥胖型Zucker大鼠24只,分为:瘦大鼠+赋形剂组,瘦大鼠+氯苯丁酯组,肥胖大鼠+赋形剂组和肥胖大鼠+氯苯丁酯组,分别给予腹腔内注射氯苯丁酯(300 mg/kg)或赋形剂(橄榄油,1 mL/kg)2周。测定血糖和胰岛素浓度,血浆游离脂肪酸、甘油三酯、胆固醇浓度,以及心脏甘油三酯和脂肪酸含量。结果氯苯丁酯可使肥胖大鼠血浆游离脂肪酸和胆固醇浓度恢复正常并可降低血浆甘油三酯和胰岛素浓度,可增加肥胖大鼠心肌甘油三酯的积聚,且心肌长链不饱和脂肪酸和单不饱和脂肪酸含量也相应增加。结论氯苯丁酯可增加肥胖Zucker大鼠心肌甘油三酯积聚,使用其治疗脂毒性心肌病应严格控制。 Objective To determine the effect of clofibrate on myocardial triglyceride accumulation in female obese Zucker rats and its role in lipotoxic heart disease. Methods Twenty four female Zucker rats were divided into four groups., lean rats+vehicle, lean rats+clofibrate, obese rats + vehicle, obese rats+clofibrate. Daily intraperitoneal injection of clofibrate (300 mg/kg) or vehicle (olive oil, 1 mL/kg) was given to the rats for two weeks. Plasma glucose, insulin, free fatty acids, triglycerdles, cholesterol, and cardiac triglycerdies and fatty acids were measured. Results Clofibrate normalized plasma free fatty acid and cholesterol and reduced plasma triglyceride and insulin in obese rats. However, clofibrate led to accumulation of heart TG and increased myocardial long-chain unsaturated and monounsaturated fatty acids in obese rats. Conclusion Clofibrate aggravates myocardial triglyceride accumulation in female obese Zuckcr rats. Further studies are needed for the use of clofibrate in treating cardiac lipid accumulation.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2008年第6期962-964,共3页 Journal of Sichuan University(Medical Sciences)
关键词 氯苯丁酯 PPARΑ 脂肪酸 甘油三酯 心脏 Clofibrate PPARα Fatty acids Triglycerdies Heart
  • 相关文献

参考文献9

  • 1Park TS, Yamashita H, Blaner WS, et al. Lipids in the heart: a source of fuel and a source of toxins. Curt Opin Lipidol, 2007; 18(3):277-282.
  • 2Unger RH. Lipotoxic diseases. Annu Rev Med, 2002; 53: 319- 336.
  • 3Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med, 2000 ; 10 (6) : 238- 245.
  • 4Barham D, Trinder P. An improved eolour reagent for the determination of blood glucose by the oxidase system. Analyst, 1972 ; 97 (151) : 142-145.
  • 5Aasum E, Belke DD, Severson DL, et al. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17. 0744, a novel PPAR-alpha activator. Am J Physiol Heart Circ Physiol, 2002 ; 283 (3) : H949-957.
  • 6Chou CJ, Haluzik M, Gregory C, et al. WY14, 643, a peroxisome proliferator-aetivated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J Biol Chem, 2002;27(27):24484-24489.
  • 7Van der Lee KA, Vork MM, De Vries JE, et al. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res,2000;41(1):41-47.
  • 8Finck BN, Lehman JJ, Leone TC, et al. The cardiac phermtype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest,2002;109(1):121-130.
  • 9Finck BN, Han X, Courtois M, et al. A critical role for PPARalpha-mediated ipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA,2003;100(3) : 1226-1231.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部